latest update:
[TrialBase DB]

trial summary · NCT07585136

Stem Cell Mobilization and Apheresis for Life-threatening Blood Disorders

Trial record from the TrialBase DB dataset, status RECRUITING, condition Bone Marrow Failure Syndrome, sponsored by St. Jude Children's Research Hospital. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT07585136phase PHASE1enrollment 12start 2026-11

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

The purpose of this study is to investigate mobilization and collection of HSPCs in patients with bone marrow failure syndromes (BMFS) using granulocyte-colony stimulating factor (otherwise known as Filgrastim) with plerixafor to demonstrate safety and feasibility of collecting HSPCs to advance gene therapy. Primary objective: \- To characterize the safety of Filgrastim plus plerixafor in participants with life threatening blood disorders as determined by the incidence of adverse events (AEs). Secondary Objectives: * To measure the mobilization effects of Filgrastim plus plerixafor in the peripheral blood in participants as determined by peak peripheral blood CD34+ counts. * To characterize the feasibility of HSPC mobilization using Filgrastim plus plerixafor as determined by peripheral blood CD34+ counts. * To estimate efficacy of Filgrastim plus plerixafor for HSPC mobilization and apheresis collection in participants as determined by the yield of CD34+ cells (CD34+ cells/kg).

Source record: https://clinicaltrials.gov/study/NCT07585136

Facts

registry idNCT07585136
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasePHASE1
study typeINTERVENTIONAL
lead conditionBone Marrow Failure Syndrome
sponsorSt. Jude Children's Research Hospital
sponsor classOTHER
enrollment12
start date2026-11
primary completion2028-12-01
completion2029-07-01
results postednot reported

Conditions

  • Bone Marrow Failure Syndrome

Interventions

  • Filgrastim
  • Plerixafor
  • Leukapheresis

Countries

  • United States

Intervention types: DRUG, PROCEDURE

Work with this record